Form 4: Surgery Partners Director Acquires Shares

Teresa DeLuca, a Director at Surgery Partners, Inc., acquired 11,670 shares of common stock on June 5, 2026, at a price of $13.71 per share.

Summary

• Teresa DeLuca, a Director of Surgery Partners, Inc. (SGRY), acquired 11,670 shares of common stock on June 5, 2026.
• The acquisition was made at a price of $13.71 per share.
• Following this transaction, DeLuca beneficially owns 56,843 shares of common stock.
• The acquired shares are subject to vesting on June 5, 2027.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents a director's investment in the company, but it is a routine disclosure and not indicative of significant new strategic information.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 11,670 shares by a director indicates a direct investment in the company's equity.

Future Outlook

The acquired shares are scheduled to vest on June 5, 2027, indicating a forward-looking commitment by the director.

Industry Context

StockSavvy.ai notes that insider transactions, such as this share acquisition by a director, are closely watched by the market as potential indicators of management's view on the company's valuation and future performance within the healthcare services sector.

Stakeholder Impact

• Shareholders may view this acquisition positively as it demonstrates insider confidence in the company's stock value.
• Employees may interpret this as a sign of stability and commitment from the board.

Next Steps

• The acquired shares will vest on June 5, 2027.

Key Dates

Keywords

Surgery Partners, SGRY, Form 4, Insider Trading, Director Transaction, Common Stock, Beneficial Ownership